We have lift off!

The countdown is over and the first print issue of Molecular BioSystems, a chemical biology journal with a particular focus at the interface between chemistry and the -omic sciences and systems biology, launches this month. Everyone involved, from editorial and production staff, through marketing and sales teams, to authors, referees and readers, are waiting for feedback from the scientific community.

The content of the new journal speaks for itself: a Highlight from Paul Workman at the UK's Institute of Cancer Research looks at the role of genomics in cancer drug development, while the first Review covers novel gene discovery systems. The first Opinion looks at why systems biology is called systems biology, and the first Method reports on the use of electrophoretic and mass spectrometric strategies for profiling lipopolysaccharides. Communications and full papers complete the range of high quality material from international authors in this impressive first issue.

In a recent Editorial¹ Thomas Kodadek and Caroline Evans (Molecular BioSystems' Editorial Board chair and editor respectively) described the new journal as 'a forum for the publication of novel work at the interface between chemistry and biology'